401 related articles for article (PubMed ID: 21558519)
1. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
[TBL] [Abstract][Full Text] [Related]
2. Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario.
Garg P; Wijeysundera HC; Yun L; Cantor WJ; Ko DT
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122664
[TBL] [Abstract][Full Text] [Related]
3. Recent changes in practice of elective percutaneous coronary intervention for stable angina.
Ahmed B; Dauerman HL; Piper WD; Robb JF; Verlee MP; Ryan TJ; Goldberg D; Boss RA; Phillips WJ; Fedele F; Butzel D; Malenka DJ;
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):300-5. PubMed ID: 21505155
[TBL] [Abstract][Full Text] [Related]
4. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
[TBL] [Abstract][Full Text] [Related]
5. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
7. The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina.
Atwater BD; Oujiri J; Wolff MR
Clin Cardiol; 2009 Aug; 32(8):E1-3. PubMed ID: 19536842
[TBL] [Abstract][Full Text] [Related]
8. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
[TBL] [Abstract][Full Text] [Related]
9. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
Boden WE
Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
[TBL] [Abstract][Full Text] [Related]
10. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
[TBL] [Abstract][Full Text] [Related]
11. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
[TBL] [Abstract][Full Text] [Related]
13. The truth and consequences of the COURAGE trial.
Kereiakes DJ; Teirstein PS; Sarembock IJ; Holmes DR; Krucoff MW; O'Neill WW; Waksman R; Williams DO; Popma JJ; Buchbinder M; Mehran R; Meredith IT; Moses JW; Stone GW
J Am Coll Cardiol; 2007 Oct; 50(16):1598-603. PubMed ID: 17936161
[TBL] [Abstract][Full Text] [Related]
14. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
Holper EM; Addo T
Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
[TBL] [Abstract][Full Text] [Related]
16. Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
Kawashima H; Serruys PW; Ono M; Hara H; O'Leary N; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Sharif F; McEvoy JW; Onuma Y;
J Am Coll Cardiol; 2021 Jul; 78(1):27-38. PubMed ID: 34210411
[TBL] [Abstract][Full Text] [Related]
17. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
18. Effect of PCI on quality of life in patients with stable coronary disease.
Weintraub WS; Spertus JA; Kolm P; Maron DJ; Zhang Z; Jurkovitz C; Zhang W; Hartigan PM; Lewis C; Veledar E; Bowen J; Dunbar SB; Deaton C; Kaufman S; O'Rourke RA; Goeree R; Barnett PG; Teo KK; Boden WE; ; Mancini GB
N Engl J Med; 2008 Aug; 359(7):677-87. PubMed ID: 18703470
[TBL] [Abstract][Full Text] [Related]
19. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.
Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
